Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
- 1 May 1991
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Clinical Immunology
- Vol. 11 (3), 117-127
- https://doi.org/10.1007/bf00918679
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185
erb
B2
Science, 1990
- Signal transduction by receptors with tyrosine kinase activityCell, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogeneCell, 1988
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988
- The Molecular Genetics of CancerScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985
- Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomasCell, 1982